Abstract
The immunological role of interleukin 27 has been reported in various inflammatory diseases, but its importance in systemic lupus erythematosus pathogenesis is not completely established. The aim of this study was to evaluate serum levels of IL-27 in SLE patients and its correlation with clinical manifestations and disease activity. IL-27 levels were assessed in 70 SLE patients and 30 healthy controls by ELISA. Clinical and laboratory parameters were recorded. Statistic analyzes were performed by Graph Prism 3.02 software. The IL-27 serum levels were significantly decreased in SLE patients compared with controls (mean 899.92 and 1,531.22 pg/ml, P = 0.0005). There was a correlation between IL-27 levels and C3 levels (P = 0.004). Nevertheless, there was no association of serum IL-27 levels with disease activity evaluated by SLEDAI score (P = 0.9605). No significant difference was found regarding IL-27 levels between SLE patients with and without nephritis, haematuria, proteinuria and positive anti-dsDNA. Correlation analysis between serum IL-27 levels and SLEDAI, SLICC, proteinuria levels, C4 and CH50 levels also showed no association. These data demonstrated decreased serum levels of IL-27 in SLE patients but further studies are needed to clarify the precise role of this cytokine and its potential use as therapeutic target.
Similar content being viewed by others
References
Yap DY, Lai KN (2010) Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advances. J Biomed Biotechnol 2010:365083
Amel-Kashipaz MR, Huggins ML, Lanyon P et al (2001) Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(−) and CD8(+) T cells in systemic lupus erythematosus. J Autoimmun 17(2):155–163
Chen DY, Chen YM, Wen MC, et al (2012) The potential role of Th17 cells and Th17-related cytokines in the pathogenesis of lupus nephritis. Lupus. 2012 Aug 14. [Epub ahead of print]
Zhao XF, Pan HF, Yuan H et al (2010) Increased serum interleukin 17 in patients with systemic lupus erythematosus. Mol Biol Rep 37:81–85
Pflanz S, Timans JC, Cheung J et al (2002) IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 16(6):779–790
Villarino AV, Stumhofer JS, Saris CJ, Kastelein RA, de Sauvage FJ, Hunter CA (2006) IL-27 limits IL-2 production during Th1 differentiation. J Immunol 176(1):237–247
Liu H, Rohowsky-Kochan C (2011) Interleukin-27-mediated suppression of human Th17 cells is associated with activation of STAT1 and suppressor of cytokine signaling protein 1. J Interferon Cytokine Res 31(5):459–469
Awasthi A, Carrier Y, Peron JP et al (2007) A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat Immunol 8(12):1380–1389
Shen H, Xia L, Xiao W, Lu J (2011) Increased levels of interleukin-27 in patients with rheumatoid arthritis. Arthritis Rheum 63(3):860–861
Yoshizaki A, Yanaba K, Iwata Y et al (2011) Elevated serum interleukin-27 levels in patients with systemic sclerosis: association with T cell, B cell and fibroblast activation. Ann Rheum Dis 70(1):194–200
Shibata S, Tada Y, Kanda N et al (2010) Possible roles of IL-27 in the pathogenesis of psoriasis. J Invest Dermatol 130(4):1034–1039
Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725
Gladman DD, Ibanez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29(2):288–291
Sugiyama N, Nakashima H, Yoshimura T et al (2008) Amelioration of human lupus-like phenotypes in MRL/lpr mice by overexpression of interleukin 27 receptor alpha (WSX-1). Ann Rheum Dis 67(10):1461–1467
Li TT, Zhang T, Chen GM et al (2010) Low level of serum interleukin 27 in patients with systemic lupus erythematosus. J Investig Med 58(5):737–739
Shimizu S, Sugiyama N, Masutani K et al (2005) Membranous glomerulonephritis development with Th2-type immune deviations in MRL/lpr mice deficient for IL-27 receptor (WSX-1). J Immunol 175(11):7185–7192
Igawa T, Nakashima H, Sadanaga A et al (2009) Deficiency in EBV-induced gene 3 (EBI3) in MRL/lpr mice results in pathological alteration of autoimmune glomerulonephritis and sialadenitis. Mod Rheumatol 19(1):33–41
Kwan BC, Tam LS, Lai KB et al (2009) The gene expression of type 17 T-helper cell-related cytokines in the urinary sediment of patients with systemic lupus erythematosus. Rheumatology (Oxford) 48(12):1491–1497
Wong CK, Ho CY, Li EK et al (2000) Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 9:589–593
Yoshimura T, Takeda A, Hamano S et al (2006) Two-sided roles of IL-27: induction of Th1 differentiation on naive CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism. J Immunol 177:5377–5385
Diveu C, McGeachy MJ, Boniface K et al (2009) IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells. J Immunol 182:5748–5756
Murugaiyan G, Mittal A, Lopez-Diego R et al (2009) IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells. J Immunol 183(4):2435–2443
Acknowledgments
This is study was supported by the Instituto Nacional de Ciência e Tecnologia para Inovação Farmacêutica (INCT_if), Fundação de Amparo à Ciência e Tecnologia do Estado de Pernambuco (FACEPE) and Financiadora de Estudos e Projetos (FINEP).
Author information
Authors and Affiliations
Corresponding author
Additional information
Angela Luzia Branco Pinto Duarte, Andréa Tavares Dantas are contributed equally to this work.
Rights and permissions
About this article
Cite this article
Duarte, A.L.B.P., Dantas, A.T., de Ataíde Mariz, H. et al. Decreased serum interleukin 27 in Brazilian systemic lupus erythematosus patients. Mol Biol Rep 40, 4889–4892 (2013). https://doi.org/10.1007/s11033-013-2588-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-013-2588-1